Literature DB >> 12865262

Mortality in Barrett's oesophagus: results from a population based study.

L A Anderson1, L J Murray, S J Murphy, D A Fitzpatrick, B T Johnston, R G P Watson, P McCarron, A T Gavin.   

Abstract

BACKGROUND: Patients with Barrett's oesophagus have an increased risk of oesophageal adenocarcinoma but this cancer only accounts for a small proportion of deaths in these patients. Other causes of death are reportedly raised in this group. We examined cause specific mortality among individuals in a population based Barrett's oesophagus register.
METHODS: We constructed a register of all patients diagnosed with columnar mucosa (including specialised intestinal metaplasia) of the oesophagus within Northern Ireland between 1993 and 1999. Deaths occurring within this cohort until 31 December 2000 were identified and mortality rates were compared with the general population.
RESULTS: Overall mortality was not raised in Barrett's patients. During 7413 person years of follow up in 2373 patients there were 253 deaths (standardised mortality ratio (SMR) 96 (95% confidence interval (CI) 84-107)). Mortality from oesophageal cancer was raised in patients with specialised intestinal metaplasia (SMR 774 (95% CI 317-1231)) but only 4.7% of patients died from this cancer. Mortality from stroke (SMR 65 (95% CI 37-93)) was significantly lower than the general population while mortality from non-cancerous digestive system diseases was significantly higher (SMR 211 (95% CI 111-311)). Mortality rates from all other causes were similar to those of the general population.
CONCLUSIONS: This study demonstrates that the overall mortality rate in patients with Barrett's oesophagus is closely similar to that of the general population. Oesophageal cancer mortality was raised but is an uncommon cause of death in these patients who also appear to have a reduced risk of death from stroke.

Entities:  

Mesh:

Year:  2003        PMID: 12865262      PMCID: PMC1773743          DOI: 10.1136/gut.52.8.1081

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Barrett's oesophagus: the continuing conundrum.

Authors:  T J McGarrity
Journal:  BMJ       Date:  2000-11-18

2.  Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation.

Authors:  V F Eckardt; G Kanzler; G Bernhard
Journal:  Am J Med       Date:  2001-07       Impact factor: 4.965

3.  Chronic peptic ulcer of the oesophagus and 'oesophagitis'.

Authors:  N R BARRETT
Journal:  Br J Surg       Date:  1950-10       Impact factor: 6.939

4.  The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.

Authors:  A J Cameron; B J Ott; W S Payne
Journal:  N Engl J Med       Date:  1985-10-03       Impact factor: 91.245

Review 5.  The changing epidemiology of esophageal cancer.

Authors:  W J Blot; J K McLaughlin
Journal:  Semin Oncol       Date:  1999-10       Impact factor: 4.929

6.  Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.

Authors:  A A Botterweck; L J Schouten; A Volovics; E Dorant; P A van Den Brandt
Journal:  Int J Epidemiol       Date:  2000-08       Impact factor: 7.196

Review 7.  Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.

Authors:  P S Rana; D A Johnston
Journal:  Dis Esophagus       Date:  2000       Impact factor: 3.429

8.  Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study.

Authors:  C E Macdonald; A C Wicks; R J Playford
Journal:  BMJ       Date:  2000-11-18

9.  Adenocarcinoma and Barrett's esophagus. An overrated risk?

Authors:  S J Spechler; A H Robbins; H B Rubins; M E Vincent; T Heeren; W G Doos; T Colton; E M Schimmel
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

10.  Barrett's oesophagus and colonic tumours.

Authors:  S J Sontag; T G Schnell; G Chejfec; S O'Connell; M M Stanley; W Best; R Chintam; B Nemchausky; J Wanner; B Moroni
Journal:  Lancet       Date:  1985-04-27       Impact factor: 79.321

View more
  37 in total

1.  Barrett's oesophagus: epidemiology comes up with a surprise.

Authors:  R C Heading
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

Review 2.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  Barrett's esophagus and the increasing role of endoluminal therapy.

Authors:  Michael S Smith; Charles J Lightdale
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

4.  The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid.

Authors:  Heather B Roesly; Mohammad R Khan; Hwu Dau Rw Chen; Kimberly A Hill; Nirushan Narendran; George S Watts; Xiaoxin Chen; Katerina Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-02       Impact factor: 4.052

Review 5.  Gastro-oesophageal reflux disease.

Authors:  Mark Fox; Ian Forgacs
Journal:  BMJ       Date:  2006-01-14

6.  TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort.

Authors:  L Murray; A Sedo; M Scott; D McManus; J M Sloan; L J Hardie; D Forman; C P Wild
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

7.  Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus.

Authors:  Ganapathy A Prasad; Kenneth K Wang; Navtej S Buttar; Louis-Michel Wongkeesong; Kausilia K Krishnadath; Francis C Nichols; Lori S Lutzke; Lynn S Borkenhagen
Journal:  Gastroenterology       Date:  2007-02-07       Impact factor: 22.682

8.  The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort.

Authors:  B T Theron; H Padmanabhan; H Aladin; P Smith; E Campbell; P Nightingale; B T Cooper; N J Trudgill
Journal:  United European Gastroenterol J       Date:  2016-02-19       Impact factor: 4.623

9.  New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management.

Authors:  Brian J Reid; Rumen Kostadinov; Carlo C Maley
Journal:  Clin Cancer Res       Date:  2011-04-15       Impact factor: 12.531

10.  Chemoprevention in Barrett's esophagus: are we there yet, are we there yet...?

Authors:  Douglas A Corley
Journal:  Clin Gastroenterol Hepatol       Date:  2009-09-16       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.